SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 29.19 |
Enterprise Value ($M) | 29.33 |
Book Value ($M) | -1.50 |
Book Value / Share | -0.00 |
Price / Book | -19.52 |
NCAV ($M) | -1.50 |
NCAV / Share | -0.00 |
Price / NCAV | -19.52 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -4.72 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.01 |
Assets | 0.01 |
Liabilities | 1.51 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
FORM 10-Q/A Amendment No. 1 | ||
FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
Similar Companies | |
---|---|
AAVXF – ABIVAX Société Anonyme | ABCZF – Abcam Limited |
ABMC – American Bio Medica Corporation | ACUR – Acura Pharmaceuticals, Inc. |
ACUT – AccuStem Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io